Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2/3 Safety and Efficacy Trial of the REVEAL 475 System for Bevonescein-Assisted Intra-Operative Visualization of Nerves in Head and Neck Surgery

NCT06227585 is registered in ClinicalTrials.gov with Alume Biosciences, Inc. as lead sponsor.

NCT NCT06227585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06227585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2/3 Safety and Efficacy Trial of the REVEAL 475 System for Bevonescein-Assisted Intra-Operative Visualization of Nerves in Head and Neck Surgery
Lead sponsor
Alume Biosciences, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
November 29, 2023
Completion date
January 5, 2026
Enrollment
155 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck surgery